A Randomized Controlled Observer Blind Trial to Compare the Immunogenicity and Acceptability of a MF59-adjuvanted Influenza Vaccine Compared to an Inactivated Influenza Vaccine as a Preferred Influenza Vaccine Priming Strategy for Naive Infants 6 to <24 Months of Age
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2018
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 05 Nov 2018 Status changed from not yet recruiting to recruiting.
- 24 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Oct 2018.
- 21 Sep 2018 New trial record